| Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity L Cantuti-Castelvetri, R Ojha, LD Pedro, M Djannatian, J Franz, ... Science 370 (6518), 856-860, 2020 | 1703 | 2020 |
| Precision targeting of tumor macrophages with a CD206 binding peptide P Scodeller, L Simón-Gracia, S Kopanchuk, A Tobi, K Kilk, P Säälik, ... Scientific reports 7 (1), 1-12, 2017 | 157 | 2017 |
| Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system L Cantuti-Castelvetri, R Ojha, LD Pedro, M Djannatian, J Franz, ... BioRxiv, 2020.06. 07.137802, 2020 | 119 | 2020 |
| Tumor-penetrating nanosystem strongly suppresses breast tumor growth S Sharma, VR Kotamraju, T Molder, A Tobi, T Teesalu, E Ruoslahti Nano letters 17 (3), 1356-1364, 2017 | 93 | 2017 |
| Peptide-guided nanoparticles for glioblastoma targeting P Säälik, P Lingasamy, K Toome, I Mastandrea, L Rousso-Noori, A Tobi, ... Journal of controlled release 308, 109-118, 2019 | 64 | 2019 |
| Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles H Hunt, L Simón-Gracia, A Tobi, VR Kotamraju, S Sharma, M Nigul, ... Journal of Controlled Release 260, 142-153, 2017 | 64 | 2017 |
| Tumor-penetrating peptide for systemic targeting of Tenascin-C P Lingasamy, A Tobi, K Kurm, S Kopanchuk, A Sudakov, M Salumäe, ... Scientific Reports 10 (1), 5809, 2020 | 43 | 2020 |
| Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery P Lingasamy, A Tobi, M Haugas, H Hunt, P Paiste, T Asser, T Rätsep, ... Biomaterials 219, 119373, 2019 | 42 | 2019 |
| In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissues K Pleiko, K Põšnograjeva, M Haugas, P Paiste, A Tobi, K Kurm, ... Nucleic acids research 49 (7), e38-e38, 2021 | 27 | 2021 |
| Exposed CendR domain in homing peptide yields skin-targeted therapeutic in epidermolysis bullosa T Pemmari, L Ivanova, U May, P Lingasamy, A Tobi, A Pasternack, ... Molecular therapy 28 (8), 1833-1845, 2020 | 22 | 2020 |
| ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1 B Simonetti, JL Daly, L Simón-Gracia, K Klein, S Weeratunga, ... Proceedings of the National Academy of Sciences 119 (25), e2201980119, 2022 | 19 | 2022 |
| Ratiometric in vivo auditioning of targeted silver nanoparticles K Toome, AMA Willmore, P Paiste, A Tobi, KN Sugahara, K Kirsimäe, ... Nanoscale 9 (28), 10094-10100, 2017 | 16 | 2017 |
| Silver nanocarriers targeted with a CendR peptide potentiate the cytotoxic activity of an anticancer drug A Tobi, AMA Willmore, K Kilk, V Sidorenko, GB Braun, U Soomets, ... Advanced Therapeutics 4 (1), 2000097, 2021 | 14 | 2021 |
| Homing peptide-based targeting of tenascin-C and fibronectin in endometriosis L Simón-Gracia, K Kiisholts, V Petrikaitė, A Tobi, M Saare, P Lingasamy, ... Nanomaterials 11 (12), 3257, 2021 | 10 | 2021 |
| PL1 peptide engages acidic surfaces on tumor-associated fibronectin and tenascin isoforms to trigger cellular uptake P Lingasamy, K Põšnograjeva, S Kopanchuk, A Tobi, A Rinken, ... Pharmaceutics 13 (12), 1998, 2021 | 8 | 2021 |
| ESCPE-1 Mediates Retrograde Endosomal Sorting of the SARS-CoV-2 Host Factor Neuropilin-1 (preprint) B Simonetti, JL Daly, L Simon-Gracia, K Klein, S Weeratunga, ... | | 2022 |
| Abstract LB-062: Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles T Teesalu, H Hedi, L Simón-Gracia, A Tobi, KN Sugahara, S Sharma, ... Cancer Research 77 (13_Supplement), LB-062-LB-062, 2017 | | 2017 |
| P32-targeting TT1 peptide delivers nanoparticles to intracranial glioblastomas P Säälik, H Hunt, A Tobi, AMA Willmore, K Toome, S Sharma, ... Cancer Research 76 (14_Supplement), 1343-1343, 2016 | | 2016 |
| Tenascin-C binding peptides for cancer targeting P Lingasamy, A Tobi, H Hunt, P Säälik, M Salumäe, T Teesalu, T Teesalu Cancer Research 76 (14_Supplement), 2164-2164, 2016 | | 2016 |
| Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis Bullosa T Pemmari, L Ivanova, U May, P Lingasamy, A Tobi, A Pasternack, ... organ 5, 8, 0 | | |
Tambet TeesaluUniversity of Tartu, EstoniaVerified email at ut.ee
